Midazolam and flumazenil: the agonist-antagonist concept for sedation and anaesthesia
- PMID: 2109462
- DOI: 10.1111/j.1399-6576.1990.tb03197.x
Midazolam and flumazenil: the agonist-antagonist concept for sedation and anaesthesia
Similar articles
-
Midazolam and flumazenil in neuroanaesthesia.Acta Anaesthesiol Scand Suppl. 1990;92:96-102. doi: 10.1111/j.1399-6576.1990.tb03194.x. Acta Anaesthesiol Scand Suppl. 1990. PMID: 2109478 Review.
-
Midazolam and flumazenil--the agonist-antagonist concept for sedation and anaesthesia. Proceedings of an international symposium. Sardinia, April 1989.Acta Anaesthesiol Scand Suppl. 1990;92:1-109. Acta Anaesthesiol Scand Suppl. 1990. PMID: 2109461 No abstract available.
-
Cerebrovascular and metabolic effects of midazolam and flumazenil.Acta Anaesthesiol Scand Suppl. 1990;92:75-7. doi: 10.1111/j.1399-6576.1990.tb03189.x. Acta Anaesthesiol Scand Suppl. 1990. PMID: 2109475 Review. No abstract available.
-
Effects of flumazenil on cerebral blood flow and oxygen consumption after midazolam anaesthesia for craniotomy.Br J Anaesth. 1991 Sep;67(3):277-80. doi: 10.1093/bja/67.3.277. Br J Anaesth. 1991. PMID: 1911013 Clinical Trial.
-
The reversal of midazolam sedation with the benzodiazepine antagonist flumazenil (Anexate).N Z Med J. 1988 Sep 14;101(853):571-2. N Z Med J. 1988. PMID: 3138580
Cited by
-
Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.Psychopharmacology (Berl). 1994 Mar;114(2):257-61. doi: 10.1007/BF02244846. Psychopharmacology (Berl). 1994. PMID: 7838917 Clinical Trial.